Le Lézard

Communiqués de presse par sujet : Essais cliniques / Découvertes médicales

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

29 septembre 2017

07:30
SHELTON, Conn., Sept. 29, 2017 /PRNewswire/ -- NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), reports that it has filed its financial year end annual report (Form 10-K) with the Securities and Exchange Commission (SEC) on Thursday,...

04:27
LUND, Sweden, September 29, 2017 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced the company's Marketing Authorization Application (MAA) for the investigational, weekly and monthly CAM2038 buprenorphine depots for the treatment of opioid...

02:00
Les résultats à un an de plus de 100 patients dans 9 hôpitaux répartis dans 4 pays européens démontrent que l'iFuse Implanttm est sûr et plus efficace que les soins conservateurs SAN JOSE, Californie, le 29 septembre 2017 /PRNewswire/ -- SI-BONE,...


28 septembre 2017

16:30
Safety Review Committee Reports Encouraging Drug Distribution and Tolerability TORONTO and HOUSTON, Sept. 28, 2017 /CNW/ - Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (TSX: MDNA), a clinical stage immuno-oncology company, announced...

15:11
SAN DIEGO, Sept. 28, 2017 /PRNewswire/ -- ViaCyte, Inc., a privately-held regenerative medicine company, today announced that the California Institute for Regenerative Medicine (CIRM) approved a grant of $20 million to support the clinical...

14:00
LOS ANGELES, Sept. 28, 2017 /PRNewswire/ -- Med-X, Inc. (Med-X) With all regulatory matters resolved in its favor, Med-X, Inc. is pleased to announce a return to Regulation A+ equity crowdfunding via the StartEngine platform. Med-X's offering was...

11:02
OSAKA, Japan and FLORHAM PARK, N.J., Sept. 28, 2017 /PRNewswire/ -- Shionogi & Co., Ltd. (hereafter "Shionogi") today announced it will share the latest data on cefiderocol (S-649266), an investigational siderophore cephalosporin with a novel...

10:00
JERSEY CITY, N.J., Sept. 28, 2017 /PRNewswire/ -- TrialScope, the global leader in clinical trial transparency and compliance solutions, announced new findings from its sponsor survey on clinical trial results sharing practices, at CBI's second...

09:00
SANTA CLARA, California and WASHINGTON, September 28, 2017 /PRNewswire/ -- Acceliant, the global leader in e-clinical data management solutions, has partnered with Turacoz, a leading medical communications company that provides customized,...

08:00
PALO ALTO, Calif., Sept. 28, 2017 /PRNewswire/ -- Eidos Therapeutics, a subsidiary of BridgeBio Pharma, today announced dosing of the first healthy adult cohort in the first-in-human, Phase 1 clinical trial of AG10 (NCT03294707). Eidos is developing...


27 septembre 2017

16:54
FORT WASHINGTON, Pa., Sept. 27, 2017 /PRNewswire-USNewswire/ -- Historically, randomized controlled trials have served as the state-of-the-art method for determining the efficacy and safety of new, innovative treatment regimens for patients with...

16:48
SAN DIEGO, Sept. 27, 2017 /PRNewswire/ -- Genelux Corporation, a privately-held biopharmaceutical company focused on the development of its proprietary oncolytic immunotherapy platform, today announced that it has treated the first patient in a Phase...

14:30
PRINCETON, N.J., Sept. 27, 2017 /PRNewswire/ -- Braeburn Pharmaceuticals, Inc. (Braeburn) today participated in the Third Meeting of the President's Commission on Combating Drug Addiction and the Opioid Crisis held in the Eisenhower Executive...

10:48
CAESAREA, Israel and NEW YORK, Sept. 27, 2017 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced that its MyDario product is expected to appear on The...

09:00
REDWOOD SHORES, Calif., Sept. 27, 2017 /PRNewswire/ -- PROCEPT BioRobotics, a Silicon Valley robotics company developing intelligent surgical solutions to treat prostate disease, has announced that the first patients have been treated in the WATER II...

08:45
DENVER, Sept. 27, 2017 /PRNewswire/ -- The Colorado Center for Reproductive Medicine (CCRM), a leading fertility treatment network, is conducting a clinical research study to explore how its natural antioxidant supplement, GameteHealth, could...

08:30
TEL AVIV, Israel, Sept. 27, 2017 /PRNewswire/ -- Therapix Biosciences Ltd. (Nasdaq: TRPX) ("Therapix" or the "Company"), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based drugs, today announced new...

08:30
PARSIPPANY, N.J., Sept. 27, 2017 /PRNewswire/ -- Castle Creek Pharmaceuticals (CCP), a global company dedicated to delivering transformative therapies to patients with orphan dermatologic and other underserved conditions, today announced the...

08:00
SAN DIEGO, Sept. 27, 2017 /PRNewswire/ -- OncoSec Medical Incorporated ("OncoSec") (NASDAQ:ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today presented an overview of the comprehensive immune monitoring data from the...

07:36
SAN DIEGO, Sept. 27, 2017 /PRNewswire/ -- Agena Bioscience today announced a comparative study published in PLOS ONE highlighting the use of its mass spectrometry-based platform and new, highly sensitive iPLEX® HS chemistry for detection of somatic...

07:11
SARASOTA, Fla., Sept. 27, 2017 /PRNewswire/ -- Lakewood-Amedex Inc., a leading developer of novel anti-infective pharmaceuticals, today announced it will present at the BioPharm America Conference top-line Phase 1/2a clinical data for its lead...

07:00
Funding will Advance Proprietary Imaging Technology Designed to Assess Coronary Artery Disease in a Revolutionary Way Renowned Medical Device Expert Dr. Aaron Berez Joins Board of Directors RESEARCH TRIANGLE PARK, N.C. and TORONTO, Sept. 27, 2017...

07:00
THE WOODLANDS, Texas, Sept. 27, 2017 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the company has initiated dosing in a Phase 1 study of LX9211, an orally-administered small molecule for the treatment of neuropathic...

07:00
ISFIYA, Israel and BOSTON, Sept. 27, 2017 /PRNewswire/ --Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for...

04:00
STEVENAGE, England, September 27, 2017 /PRNewswire/ -- First-in-class once daily NT-814 spun out of NeRRe Therapeutics into new company  KaNDy Therapeutics has been launched today to maximise the value of NT-814, a potential breakthrough medicine...

04:00
DARMSTADT, Germany and NEW YORK, September 27, 2017 /PRNewswire/ -- Not intended for UK-based media    First-ever treatment indicated for curatively unresectable Merkel cell carcinoma (MCC) and first anti-PD-L1 to be available in Japan   ...

03:00
One-Year Results for more than 100 patients at 9 Hospitals in 4 European Countries Show that the iFuse Implanttm is Safe and More Effective than Conservative Care SAN JOSE, California, Sept. 27, 2017 /PRNewswire/ -- SI-BONE, Inc., an innovative...


26 septembre 2017

19:00
WASHINGTON, Sept. 26, 2017 /PRNewswire/ -- An article published in Experimental Biology and Medicine (Volume 242, Issue 15, September 2017) identifies Opioid Growth Factor (OGF) as a novel biomarker for the onset and progression of multiple sclerosis...

15:00
IOWA CITY, Iowa, Sept. 26, 2017 /PRNewswire/ -- CompleWare and VIDA announce a joint marketing agreement promoting complementary respiratory services. Their partnership will deploy a best-in-class pulmonary platform and excellence in clinical trial...

14:30
ACTON, Mass., Sept. 26, 2017 /PRNewswire/ -- Psychemedics Corporation (NASDAQ:PMD), hair testing pioneer and global leader for over thirty years, announced the launch of its FDA-Cleared Benzodiazepines hair test.  The test detects numerous...

13:17
DENVER, Sept. 26, 2017 /PRNewswire/ -- The rabies vaccine is extremely effective at preventing this fatal disease in dogs, but new research, funded by Morris Animal Foundation, shows the vaccine may have a positive impact on overall canine health as...

13:00
SAN FRANCISCO, Sept. 26, 2017 /PRNewswire/ -- goBalto, Inc., the leading provider of cloud-based clinical study startup (SSU) solutions, announced today that PSI CRO has chosen goBalto's complete suite of SSU applications for all studies on a...

11:30
NEW YORK, Sept. 26, 2017 /PRNewswire-USNewswire/ -- A new study finds that genetic testing can help determine the safest dose of the blood thinner warfarin, with fewer side effects, in patients undergoing joint replacement surgery....

11:26
ORLANDO, Fla., Sept. 26, 2017 /PRNewswire/ -- The United States Patent and Trademark Office recently awarded Florida-based Valensa International two new patents, its 17th and 18th in this area, locking down patent protection for the core...

10:00
SAN DIEGO, Sept. 26, 2017 /PRNewswire/ -- Neurana Pharmaceuticals Inc., a specialty pharmaceutical company focused on the development and commercialization of products that address unmet therapeutic needs of the central nervous system, today...

09:40
ATLANTA, Sept. 26, 2017 /PRNewswire/ -- On the heels of milestone eye care trials aimed at lowering the risk of blindness among diabetic patients nationwide, Illuma Care Connections will demonstrate its unique technology platform to hundreds of...

09:23
RAANANA, Israel, Sept. 26, 2017 /PRNewswire/ -- XTL Biopharmaceuticals Ltd.(NASDAQ: XTLB) (TASE: XTLB.TA)("XTL" or the "Company"), a clinical-stage biopharmaceutical company developing treatments for autoimmune diseases, today announced financial...

09:00
CENTER VALLEY, Pa., Sept. 26, 2017 /PRNewswire/ -- Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today the results of a study conducted...

09:00
SAN DIEGO, Sept. 26, 2017 /PRNewswire/ -- AltheaDx, Inc. ("AltheaDx" or the "Company"), a commercial stage molecular diagnostics company specializing in the field of personalized medicine, announced today that the results from its clinical trial have...

09:00
REDWOOD CITY, Calif., Sept. 26, 2017 /PRNewswire/ -- Guardant Health announced that it received an investigational device exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to provide genomic testing for a clinical trial...

08:30
SAN DIEGO, Sept. 26, 2017 /PRNewswire/ -- AVACEN Medical, Inc. (AVACEN) announced that its AVACEN 100 Class ll medical device previously licensed for treating joint pain associated with arthritis and offering drug-free muscular relaxation in Canada...

08:00
RICHLAND, Wash., Sept. 26, 2017 /PRNewswire/ -- IsoRay, Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, head and neck and...

07:30
SUNNYVALE, California, September 26, 2017 /PRNewswire/ -- First Study to Evaluate the Use of Stereotactic Body Radiation Therapy in Low-Risk Prostate Cancer 10 Years Post Treatment  Accuray Incorporated (NASDAQ: ARAY) announced today that data from...

07:06
BASEL, Switzerland, Sept. 26, 2017 /PRNewswire/ -- Today our subsidiary Axovant announced topline results from its Phase 3 MINDSET trial of intepirdine in mild-to-moderate Alzheimer's disease. Unfortunately, intepirdine did not achieve a...

07:01
The first plant-based seasonal flu vaccine candidate reaches final clinical stage QUÉBEC CITY, Sept. 26, 2017 /CNW Telbec/ - Medicago, a Canadian biopharmaceutical company and leader in the development and production of plant-based vaccines and...

07:01
QUÉBEC CITY, September 26, 2017 /PRNewswire/ --  Le premier vaccin à particules pseudo-virales contre la grippe saisonnière fabriqué sur plantes entre dans sa phase finale d'essais cliniques  Medicago, une des plus importantes sociétés de...

07:00
BASEL, Switzerland, Sept. 26, 2017 /PRNewswire/ -- Axovant Sciences (NASDAQ: AXON) today announced that the Phase 3 MINDSET clinical trial of its investigational drug intepirdine in patients with mild to moderate Alzheimer's disease (AD) who were...

07:00
TEL AVIV, Israel, September 26, 2017 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, announced today the initiation of a Phase 1b/2 trial for BL-8040 in...

07:00
LOS ANGELES, Sept. 26, 2017 /PRNewswire/ -- Capricor Therapeutics, Inc. (NASDAQ: CAPR), which is developing biological therapies for Duchenne muscular dystrophy (DMD) and other rare diseases, today announced that the national principal investigator...

06:00
MISGAV, Israel, September 26, 2017 /PRNewswire/ -- Fidmi Medical Ltd. ("Fidmi"), a portfolio company of The Trendlines Group ("Trendlines") (SGX: 42T) (OTCQX: TRNLY), announced that it received an investment of US$2 million from B. Braun Melsungen...

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16